Back to All NewsInMode Announces U.S. Patent for Fractional RF (Morpheus8)
Posted By American Med Spa Association, Wednesday, November 11, 2020
Share
InMode Ltd., a leading global provider of innovative medical technologies, has announced that the U.S. Patent and Trademark Office has granted to InMode Patent No. 10.799.285 covering its Morpheus8 full-body fractional radiofrequency (RF) technology.
Since its inception, InMode has invested significantly in R&D to independently develop state-of-the-art electro-surgical bi-polar radiofrequency devices, bringing to market breakthrough surgical procedures for the face, body and skin, as well as women's health and wellness. Through its ongoing commitment to R&D, InMode has become a leader in disruptive technology and is credited with pioneering full body fractional RF technology through the commercialization of the Morpheus8 Subdermal Adipose Remodeling (SARD) device.
Read more at PR Newswire >>
Since its inception, InMode has invested significantly in R&D to independently develop state-of-the-art electro-surgical bi-polar radiofrequency devices, bringing to market breakthrough surgical procedures for the face, body and skin, as well as women's health and wellness. Through its ongoing commitment to R&D, InMode has become a leader in disruptive technology and is credited with pioneering full body fractional RF technology through the commercialization of the Morpheus8 Subdermal Adipose Remodeling (SARD) device.
Read more at PR Newswire >>
